文献速递系统性红斑狼疮血管炎

狼疮性肾炎患者静脉血栓栓塞的发生率与危险因素:一项队列研究

Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究纳入324例经活检证实的狼疮性肾炎患者,随访9.9年期间30例(9.3%)发生静脉血栓栓塞,中位首次事件时间为4.4年。多因素模型显示SLEDAI-2K评分(HR=1.05,95%CI:1.01-1.10)和蛋白尿水平(HR=1.26,95%CI:1.08-1.47)与静脉血栓栓塞独立相关。

要点

  • 狼疮性肾炎患者静脉血栓栓塞发生率为9.3%,中位首次事件时间为4.4年。
  • SLEDAI-2K评分与静脉血栓栓塞独立相关(HR=1.05,95%CI:1.01-1.10)。
  • 蛋白尿水平与静脉血栓栓塞独立相关(HR=1.26,95%CI:1.08-1.47)。

核心结论

  • 静脉血栓栓塞可发生于狼疮性肾炎病程的任何阶段,疾病活动度和蛋白尿是其主要危险因素。

研究设计与样本

  • 前瞻性观察性队列研究,纳入1970年至2024年间经活检证实的狼疮性肾炎患者324例,中位随访9.9年(IQR:5.0-16.4)。
  • 采用时变单变量和多变量病因特异性Cox比例风险模型,以死亡为竞争风险。

主要发现

  • 324例患者中30例(9.3%)发生静脉血栓栓塞,共34次事件;从狼疮性肾炎起病至首次事件的中位时间为4.4年(IQR:0.1-14.1)。
  • 大多数事件为孤立性(86.7%),包括19例深静脉血栓(59.4%)、5例肺栓塞和2例涉及其他静脉床的事件。
  • 多变量模型中,SLEDAI-2K评分与静脉血栓栓塞独立相关(HR=1.05,95%CI:1.01-1.10)。
  • 多变量模型中,蛋白尿水平与静脉血栓栓塞独立相关(HR=1.26,95%CI:1.08-1.47)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Venous thromboembolism (VTE) is a known complication of SLE, yet there is a lack of high-quality studies specifically focused on LN. This study aimed to assess the frequency of VTE in patients with LN and identify risk factors for its development. METHODS: We included patients with biopsy-proven LN from a prospective observational cohort followed between 1970 and 2024. The primary outcome, VTE occurring after the onset of LN, was monitored longitudinally, and the time to the first event was calculated. Time-varying univariable and multivariable cause-specific Cox proportional hazards models were used to identify factors associated with the first VTE, with death considered a competing risk. RESULTS: A total of 324 patients were included, with a mean age of 34.2 years [interquartile range (IQR): 25.9-43.0] at LN onset. Over a long-term follow-up period of 9.9 years (IQR: 5.0-16.4), 30 patients (9.3%) developed VTE, with a total of 34 events. The median time to the first event from LN onset was 4.4 years (IQR, 0.1-14.1). Most events were isolated (86.7%), including 19 deep vein thromboses (DVTs, 59.4%), 5 pulmonary embolisms (PEs), and 2 events involving other venous beds. In the multivariable model, the following factors were independently associated with the development of VTE: the SLEDAI-2K score [hazard ratio (HR) = 1.05, 95% CI: 1.01-1.10] and proteinuria level (HR = 1.26, 95% CI: 1.08-1.47). CONCLUSION: VTE can complicate the course of LN at any stage. Disease activity and proteinuria are the primary risk factors for its development.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Kharouf F, Mehta P, Li Q, et al. Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study. Rheumatology (Oxford). 2026. PMID: 40891890. doi:10.1093/rheumatology/keaf464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。